Intellectual Property India Publishes Patent Application for 'Erythroid Lineages Derived From Pluripotent Cells' Filed by Garuda Therapeutics, Inc.

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517042914 A) filed by Garuda Therapeutics, Inc., Cambridge, U.S.A., on May 2, for 'erythroid lineages derived from pluripotent cells.'

Inventor(s) include Shah, Dhvanit.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure, in various aspects and embodiments, provides methods for generating hematopoietic lineages for cell therapy, including erythroid progenitor cells, progenitor erythroblasts, granulocyte-macrophage progenitor cells (GMPs), and megakaryocyte erythroid progenitor cells (MEPs), and erythroid cells. In various em...